DEPLOYDatabase

Incident · Regulatory action

FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant

The FDA granted Breakthrough Device Designation to NIA Therapeutics' Smart Neurostimulation System (SNS) for traumatic brain injury-related memory loss — the first device ever to earn this designation for TBI memory loss. The implantable BCI records from 60 channels across 4 brain regions and delivers closed-loop stimulation to restore memory encoding.

Occurred 2026-03-01 · Nia Therapeutics · Investigated by FDA

How to read this record

Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.
Track FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant

Machine-readable surfaces

Sources (1)

  1. https://www.fda.gov/

Common questions

What happened in FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant?
The FDA granted Breakthrough Device Designation to NIA Therapeutics' Smart Neurostimulation System (SNS) for traumatic brain injury-related memory loss — the first device ever to earn this designation for TBI memory loss. The implantable BCI records from 60 channels across 4 brain regions and delivers closed-loop stimulation to restore memory encoding.
When did this incident occur?
The incident is recorded as occurring on March 1, 2026 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
Who was involved in FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant?
The incident is recorded as involving Nia Therapeutics on the DEPLOY registry. No specific robot model is linked to this incident in the registry.
Has anyone responded to FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant?
No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant?
This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-08-23

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-08-23

Sources by quality tier

1
primary-fda-database
FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for FDA grants Breakthrough Device Designation for NIA Therapeutics memory restoration implant.

Deploy Watch

Track this incident.

We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.

Canonical ID e30d055e-849c-4881-83ff-6b3415172402